A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)

Clinical trial NCT06402630 · COMPLETED

Trial details

NCT number: NCT06402630
Sponsor: Soterios Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia Areata

Start date: 2022-03-23
Primary completion: 2024-04-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.